DGX Quest Diagnostics
- Price as of: Jul 28, 05:04 PM EDT
- Medical laboratories & research
DGX Stock Dividend DataAdd DGX to Watchlist
DGX Daily Snapshot
- Quote Time:
- Jul 28, 05:04 PM
- Today's Volume:
- Open Price:
- Day's Range:
- $70.42 - $72.39
- Previous Close:
- 52 Week Low / High:
- $56.27 - $89.00
- Percent Off 52 Week High:
DGX Dividend Growth History
Last 5 Yrs
Last 3 Yrs
|Reveal More Dividend Growth History for DGX||47.7%||7.5%||3 years|
DGX Dividend History
|Payout Amount||Declared Date||Ex-Dividend Date||Record Date||Pay Date ▼||Qualified Dividend?||Payout Type||Frequency|
DGX Company Profile
Quest Diagnostics- (DGX)-provides diagnostic testing, information, and services in the United States. The company offers routine tests, including blood chemistries, blood cholesterol levels, complete blood cell counts, urinalyses, pregnancy and other prenatal tests, alcohol and other substance-abuse tests, and allergy tests. As of December 31, 2007, it operated a network of approximately 2,100 patient service centers and principal laboratories, as well as approximately 150 smaller laboratories. The company was founded in 1967 and is headquartered in Madison, New Jersey.
Quest Diagnostics News
March 03, 2015
Before Tuesday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the important analyst commentary for investors.
March 27, 2015
Before Friday’s opening bell, a number of big name dividend stocks were the subject of analyst moves. Below, we highlight the most important analyst commentary for investors.
Apr 3, 2014Ex-dividend dates are very important to dividend investors, since you must purchase a stock prior to its ex-dividend date in order to receive its...
Mar 11, 2014These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Dick's Sporting...
Jan 30, 2014Another busy day on the Street, as stocks saw some much needed relief and saw 12 companies announce increases to their dividend payouts. Aimco...
Dec 12, 2013These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Southwest Airlines...
Dec 11, 2013These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Visa () - up...
Dec 10, 2013These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Barrick Gold...
Quest Diagnostics Q3 Profit Climbs, But Adjusted Net from Continuing Operations Misses Estimates (DGX)Oct 17, 2013Before the opening bell on Thursday, diagnostic testing and services provider Quest Diagnostics Inc (DGX) reported a rise in third quarter profits, despite a decline in revenues. However, both adjusted earnings from continuing operations and revenues came up short of analysts' views. The Madison, New Jersey-based company posted a third quarter net income of $405.1 million, or $2.68 per share, up significantly from the $163.1 million, or $1.01 per share, earned in the same quarter a year ago. Quest Diagnostics' income from continuing operations came in at $402.7 million, or $2.66 per share, versus last year's third quarter income from continuing operations of $158.6 million, or 98 cents per share. On an adjusted basis, the company's net income from continuing operations was $154 million, or $1.02 per share, in the third quarter. According to analysts polled by Thomson Reuters, the company was expected to earn an adjusted $1.17 per share in the quarter. Quest Diagnostics' net revenues in the quarter edged lower to $1.79 billion from $1.82 billion in the prior year. On average, analysts were expecting the company to post revenues of $1.82 billion in the third quarter. Looking ahead to full year results, the company expects earnings from continuing operations to come in between $3.85 and $3.95 per share; previously, Quest Diagnostics had estimated earnings to be between $4.35 and $4.50 per share in fiscal 2013. Revenues are now expected to be 3.5% lower than fiscal 2012 revenues. Analysts are expecting the company to see earnings of $4.23 per share on revenues of $7.22 billion in fiscal 2013. Quest Diagnostics shares were down $1.01, or 1.72%, during morning trading on Thursday. The stock is down 1.41% year-to-date.Expand to read the full story
Oct 10, 2013These were some of the biggest dividend stock performers on the upside and the downside in today's market action. Highlights Best Buy () -...